Abiopharma

🔍 LEWIN NICHOLAS SHERIDAN (Director)

Company: ESTABLISHMENT LABS HOLDINGS INC. (ESTA)

Report Date: 2025-12-31

Detailed Transactions and Holdings:

• Acquired 343 shares of Common Shares at $72.88 per share (Direct)
  Date: 2025-12-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,076,875.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Shares (Direct)
  Date: 2025-12-31 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 19,090.00 | Footnotes: F2

Footnotes:

• F1: Represents common shares elected to be received in lieu of a quarterly cash retainer payment in accordance with the Reporting Person's prior election under the Issuer's Outside Director Compensation Policy. The common shares were issued pursuant to the Issuer's 2018 Equity Incentive Plan and determined based on the closing price of the Issuer's common shares on the last trading day of the quarter.
• F2: The shares are held by the Reporting Person's spouse.